The experimental test relies on a tiny silicon chip that captures tumor cells. It can quickly show when tumor cells become resistant to a certain drug, saving patients precious time.
The technology was developed at Massachusetts General Hospital.
Researchers say if all goes well the test could be available within the next few years.